NFATc1 (Nuclear Factor of Activated T Cells, Cytoplasmic 1), also known as NFATC1, encodes a member of the NFAT family of calcium-dependent transcription factors. Originally characterized in immune cells where they regulate cytokine gene expression, NFAT proteins are now recognized as crucial regulators of neuronal development, synaptic plasticity, and glial cell function. Dysregulated NFAT signaling contributes to neuroinflammation and neurodegeneration in Alzheimer's disease, Parkinson's disease, and other neurological disorders[1].
| Property | Value |
|---|---|
| Gene Symbol | NFATc1 / NFATC1 |
| Protein | Nuclear factor of activated T-cells, cytoplasmic 1 |
| Chromosomal Location | 18q23 |
| NCBI Gene ID | 4776 |
| UniProt ID | O95644 |
| Aliases | NFAT1, NFATc1, NF-ATc1 |
NFATc1 has multiple isoforms generated by alternative splicing:
| Isoform | Properties |
|---|---|
| NFATc1α | Full-length, highest molecular weight |
| NFATc1β | Truncated N-terminus |
| NFATc1γ | Alternative splicing variant |
| NFATc1δ | Short isoform |
| Domain | Function |
|---|---|
| N-terminal transactivation domain | Transcriptional activation |
| Rel homology region (RHR) | DNA binding |
| NFAT homology region (NHR) | Calcineurin binding, regulation |
| Serine-rich region (SRR) | Phosphorylation sites |
| Regulatory domain | Calcium/calcineurin responsiveness |
NFATc1 is a calcium-dependent transcription factor activated through a well-characterized pathway:
Phosphorylation by kinases (GSK3β, CK1) drives NFATc1 back to the cytoplasm[2].
NFATc1 regulates activity-dependent gene transcription critical for synaptic plasticity:
| Process | NFATc1 Role |
|---|---|
| Long-term potentiation (LTP) | Regulates BDNF and other plasticity genes |
| Long-term depression (LTD) | Controls AMPA receptor endocytosis genes |
| Synaptic scaling | Modifies synaptic strength |
| Dendritic spine remodeling | Regulates cytoskeletal proteins |
During development, NFATc1 controls[3]:
NFATc1 activity influences:
NFATc1 is a key transcription factor in microglia:
In astrocytes, NFATc1:
NFATc1 dysregulation is implicated in multiple aspects of AD pathogenesis[4]:
Neuroinflammation:
Synaptic Dysfunction:
Tau Pathology:
Therapeutic Potential:
NFATc1 plays complex roles in PD[5]:
Dopaminergic Neurons:
Microglial Activation:
Therapeutic Implications:
NFATc1 is activated in ALS and contributes to disease progression[wulans2019]:
Post-ischemic inflammation involves NFATc1[sato2019]:
| Agent | Mechanism | Status |
|---|---|---|
| Cyclosporine A | Calcineurin inhibitor | FDA approved (transplant) |
| Tacrolimus (FK506) | Calcineurin inhibitor | FDA approved |
| FK506 analogs | Selective NFAT inhibition | Research |
| GSK3β inhibitors | Prevent NFAT nuclear export | Research |
NFATc1 is expressed throughout the brain:
| Region | Expression | Cell Types |
|---|---|---|
| Cerebral cortex | High | Pyramidal neurons, interneurons |
| Hippocampus | High | CA1-CA3, dentate gyrus |
| Cerebellum | High | Purkinje cells |
| Basal ganglia | Moderate | Medium spiny neurons |
| Substantia nigra | Moderate | Dopaminergic neurons |
| Spinal cord | High | Motor neurons |
| Cell Type | Expression | Function |
|---|---|---|
| Excitatory neurons | High | Activity-dependent transcription |
| Inhibitory interneurons | High | Network regulation |
| Microglia | High | Immune response |
| Astrocytes | Moderate | Inflammatory gene expression |
| Oligodendrocytes | Low | Myelin genes |
NFATc1 regulates numerous target genes:
| Category | Examples | Function |
|---|---|---|
| Cytokines | IL-1β, TNF-α, IL-6 | Inflammation |
| Growth factors | BDNF, NGF | Neuronal survival |
| Synaptic proteins | Synapsin, PSD-95 | Synapse function |
| Transcription factors | c-Fos, Egr-1 | Gene cascades |
| Channel proteins | Cav1.2, Kv channels | Excitability |
| Protein | Interaction Type | Pathway |
|---|---|---|
| Calcineurin (CaN) | Dephosphorylation | Activation |
| GSK3β | Phosphorylation | Nuclear export |
| CK1 | Phosphorylation | Regulation |
| CREB | Co-activation | Transcription |
| CBP/p300 | Co-activator | Transcription |
Nguyen T, Dzialo E. NFAT in neuroinflammation and neurodegeneration. Neuropharmacology. 2023. ↩︎
Abou-Daoud K, et al. NFAT transcription factors in the brain. J Neurosci Res. 2021. ↩︎
Graef IA, et al. NFAT signaling in neural development. Cell. 1999. ↩︎
Reddy S, et al. Calcineurin-NFAT signaling in Alzheimer's disease. J Neurosci. 2022. ↩︎
Yoshida T, et al. NFATc1 in dopaminergic neurons and Parkinson's disease. Neurobiol Dis. 2018. ↩︎